Vaccination has remained the best method for preventing virus spread. The herpes simplex virus (HSV) candidate vaccines tested till now were mostly purified subunit vaccines and/or recombinant envelope glycoproteins (such as gB and gD). In many experiments performed in mice, guinea pigs and rabbits, clear-cut protection against acute virus challenge was demonstrated along with the reduction of the extent of latency, when established in the immunized host. The immunotherapeutic effect of herpes vaccines seems less convincing. However, introduction of new adjuvants, which shift the cytokine production of helper T-cells toward stimulation of cytotoxic T-cells (TH1 type cytokine response), reveals a promising development. Mathematical analysis proved that overall prophylactic vaccination of seronegative women, even when eliciting 40-60 % antibody response only, would reduce the frequency of genital herpes within the vaccinated population. Even when partially effective, immunotherapeutic vaccination might represent a suitable alternative of chronic chemotherapy in recurrent labial and genital herpes.

Institute of Virology Slovak Academy of Sciences 845 05 Bratislava Slovakia

Zobrazit více v PubMed

J Virol. 1989 May;63(5):2325-34 PubMed

J Med Virol. 1985 Jun;16(2):137-45 PubMed

J Virol. 2003 Feb;77(4):2445-51 PubMed

J Gen Virol. 1989 Dec;70 ( Pt 12):3177-85 PubMed

J Infect Dis. 1990 Apr;161(4):653-60 PubMed

J Infect Dis. 1994 Nov;170(5):1100-9 PubMed

Proc Natl Acad Sci U S A. 1987 Aug;84(15):5454-8 PubMed

Antiviral Res. 2001 Feb;49(2):83-99 PubMed

Arch Dermatol Res. 2000 Nov;292(11):542-9 PubMed

J Virol. 1995 Sep;69(9):5849-52 PubMed

Dev Biol Stand. 1981;50:201-6 PubMed

Lancet. 1994 Jun 11;343(8911):1460-3 PubMed

Acta Virol. 1998 Apr;42(2):103-18 PubMed

J Virol. 1997 Aug;71(8):5885-93 PubMed

J Gen Virol. 1989 Sep;70 ( Pt 9):2513-20 PubMed

Vaccine. 2005 Jan 4;23(7):865-72 PubMed

Arch Virol. 2002 Sep;147(9):1747-59 PubMed

J Infect Dis. 2003 Feb 15;187(4):542-9 PubMed

Virology. 1988 Jun;164(2):427-34 PubMed

Viral Immunol. 2003;16(4):475-90 PubMed

J Med Microbiol. 2002 Apr;51(4):350-357 PubMed

J Immunol. 1990 Jul 15;145(2):702-10 PubMed

Virology. 1997 May 26;232(1):1-12 PubMed

Vaccine. 2001 Jan 8;19(11-12):1538-46 PubMed

J Virol. 1992 Dec;66(12):7067-72 PubMed

J Virol. 2000 Dec;74(23):11173-80 PubMed

J Clin Invest. 1993 Jun;91(6):2837-43 PubMed

Virology. 2000 Sep 15;275(1):1-8 PubMed

J Immunol. 2001 Mar 15;166(6):4049-58 PubMed

J Gen Virol. 1997 Dec;78 ( Pt 12):3317-25 PubMed

J Virol. 1987 Dec;61(12):3820-6 PubMed

Vaccine. 2000 Aug 1;18(28):3242-53 PubMed

Vaccine. 2000 Feb 14;18(15):1522-30 PubMed

J Immunol. 2000 Jul 15;165(2):1146-52 PubMed

J Virol. 2000 Feb;74(4):2052-6 PubMed

Arch Dermatol. 1964 Jun;89:844-5 PubMed

Folia Microbiol (Praha). 2000;45(1):7-28 PubMed

Vaccine. 2000 Dec 8;19(9-10):1225-31 PubMed

J Virol. 1987 Nov;61(11):3356-64 PubMed

J Virol. 1985 Feb;53(2):634-44 PubMed

Vaccine. 2000 Mar 6;18(17):1837-46 PubMed

Arch Virol. 1977;53(1-2):55-69 PubMed

Curr Top Microbiol Immunol. 1975;70:31-50 PubMed

J Virol. 1995 Mar;69(3):1389-99 PubMed

J Virol. 1986 Jul;59(1):142-53 PubMed

Vaccine. 1986 Sep;4(3):138-50 PubMed

Arch Virol. 1981;68(2):73-80 PubMed

J Infect Dis. 1989 Mar;159(3):460-6 PubMed

J Virol. 1997 Apr;71(4):3138-45 PubMed

Br J Ophthalmol. 2000 Apr;84(4):408-12 PubMed

J Virol. 1985 Dec;56(3):757-66 PubMed

Acta Virol. 1990 Sep;34(5):477-86 PubMed

J Immunol. 1987 May 15;138(10):3431-7 PubMed

J Immunol. 1994 Jun 1;152(11):5392-7 PubMed

Microbiol Immunol. 1982;26(4):359-62 PubMed

Herpes. 2004 Aug;11 Suppl 3:161A-169A PubMed

J Virol. 1988 Jul;62(7):2265-73 PubMed

Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S935-45 PubMed

J Exp Med. 1985 Oct 1;162(4):1304-18 PubMed

Intervirology. 2001;44(1):1-7 PubMed

Lab Invest. 1994 Mar;70(3):369-80 PubMed

Med Microbiol Immunol. 1980;169(1):39-51 PubMed

J Immunol. 1999 Mar 1;162(5):2912-21 PubMed

J Infect Dis. 1998 Apr;177(4):1069-72 PubMed

J Infect Dis. 2000 Nov;182(5):1311-20 PubMed

J Virol. 1993 Nov;67(11):6903-8 PubMed

Vaccine. 1996 Sep;14(13):1230-4 PubMed

J Infect Dis. 1987 May;155(5):914-20 PubMed

Rev Med Virol. 2005 Sep-Oct;15(5):303-25 PubMed

Vaccine. 2001 Feb 28;19(15-16):1879-90 PubMed

Sex Transm Infect. 2004 Feb;80(1):24-9 PubMed

J Virol. 1999 Sep;73(9):7619-26 PubMed

Br Med Bull. 1985 Jan;41(1):86-91 PubMed

Med Microbiol Immunol. 1982;171(1):33-42 PubMed

Cell Immunol. 1983 Feb 1;75(2):348-55 PubMed

J Virol. 1986 Feb;57(2):446-55 PubMed

Acta Virol. 1992 Mar;36(2):208-22 PubMed

J Virol. 1997 Aug;71(8):5878-84 PubMed

Virology. 1995 Oct 1;212(2):481-9 PubMed

Virology. 1989 Sep;172(1):11-24 PubMed

Dev Biol Stand. 1982;52:333-44 PubMed

Microbes Infect. 2000 Jul;2(8):973-8 PubMed

J Immunol. 2003 May 1;170(9):4437-40 PubMed

J Infect Dis. 1987 Jan;155(1):28-37 PubMed

J Virol. 1988 May;62(5):1530-4 PubMed

J Infect Dis. 2000 Nov;182(5):1304-10 PubMed

Z Hautkr. 1977 Jun 1;52(11):625-8 PubMed

J Infect Dis. 1991 Feb;163(2):263-9 PubMed

Vaccine. 2005 Mar 18;23(17-18):2395-8 PubMed

J Infect Dis. 1994 Nov;170(5):1110-9 PubMed

Vaccine. 1997 Jun;15(8):857-60 PubMed

Med Microbiol Immunol. 1981;169(2):91-6 PubMed

Invest Ophthalmol Vis Sci. 2004 Feb;45(2):506-14 PubMed

Acta Virol. 1988 Jul;32(4):317-28 PubMed

Infect Immun. 1984 Feb;43(2):761-4 PubMed

J Immunol. 2002 Jan 15;168(2):834-8 PubMed

Int Immunol. 2001 Jun;13(6):799-806 PubMed

Semin Pediatr Infect Dis. 2005 Jan;16(1):31-7 PubMed

J Virol. 1988 May;62(5):1479-85 PubMed

J Infect Dis. 1987 May;155(5):921-30 PubMed

J Gen Virol. 1989 Aug;70 ( Pt 8):2149-55 PubMed

Arch Virol. 1982;71(1):75-8 PubMed

Med Microbiol Immunol. 1981;169(4):269-79 PubMed

Prog Med Virol. 1975;20:1-26 PubMed

Dev Biol Stand. 1982;52:351-8 PubMed

J Gen Virol. 1990 Apr;71 ( Pt 4):863-71 PubMed

Infect Immun. 1982 Sep;37(3):1132-7 PubMed

Adv Exp Med Biol. 1995;371B:1599-600 PubMed

J Virol. 1996 Jan;70(1):264-71 PubMed

J Immunol. 1970 May;104(5):1160-5 PubMed

Infect Immun. 1983 Jul;41(1):197-204 PubMed

Herpes. 2001 Mar;8 Suppl 1:2A-5A PubMed

Infect Immun. 1982 Oct;38(1):168-74 PubMed

Rev Infect Dis. 1985 Jan-Feb;7(1):21-30 PubMed

Curr Eye Res. 1987 Jan;6(1):167-71 PubMed

J Gen Virol. 1982 Nov;63 (Pt 1):95-101 PubMed

Intervirology. 1991;32(2):76-92 PubMed

Med Microbiol Immunol. 1990;179(3):145-59 PubMed

Vaccine. 1995 Dec;13(17):1706-12 PubMed

Virology. 1996 Jun 15;220(2):402-13 PubMed

J Immunol. 1981 Apr;126(4):1260-2 PubMed

Curr Top Microbiol Immunol. 1998;226:69-78 PubMed

Immunology. 2002 Oct;107(2):268-74 PubMed

Virology. 2000 Dec 5;278(1):207-16 PubMed

J Gen Virol. 1985 May;66 ( Pt 5):1073-85 PubMed

J Exp Med. 2002 Mar 4;195(5):651-6 PubMed

J Virol. 1984 Sep;51(3):656-61 PubMed

J Virol. 1994 Feb;68(2):927-32 PubMed

J Immunol. 1988 Sep 1;141(5):1720-7 PubMed

Cell. 1994 May 20;77(4):525-35 PubMed

Acta Virol. 1995 Feb;39(1):37-49 PubMed

Bacteriol Rev. 1964 Dec;28:472-9 PubMed

Vaccine. 1998 Nov;16(19):1822-7 PubMed

J Gen Virol. 2002 Nov;83(Pt 11):2797-2801 PubMed

J Exp Med. 1992 May 1;175(5):1337-44 PubMed

Virology. 1992 Jun;188(2):469-76 PubMed

J Virol. 1987 Nov;61(11):3607-11 PubMed

Eur J Immunol. 1999 Oct;29(10):3245-53 PubMed

Proc Natl Acad Sci U S A. 1987 Aug;84(16):5908-12 PubMed

Virology. 1990 Feb;174(2):375-87 PubMed

J Virol. 1986 Oct;60(1):157-66 PubMed

J Immunol. 2001 Mar 1;166(5):3451-7 PubMed

J Gen Virol. 1999 May;80 ( Pt 5):1271-1282 PubMed

Science. 1990 Nov 30;250(4985):1262-6 PubMed

J Gen Virol. 2002 Oct;83(Pt 10):2361-2365 PubMed

J Gen Virol. 1987 Mar;68 ( Pt 3):825-33 PubMed

J Clin Invest. 1989 Feb;83(2):490-6 PubMed

J Infect Dis. 1997 Nov;176(5):1129-34 PubMed

Am J Reprod Immunol. 2001 Dec;46(6):420-4 PubMed

Curr Top Microbiol Immunol. 1998;232:149-77 PubMed

J Infect Dis. 1988 Dec;158(6):1382-6 PubMed

Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):411-8 PubMed

N Engl J Med. 2002 Nov 21;347(21):1652-61 PubMed

J Gen Virol. 1988 Jul;69 ( Pt 7):1731-4 PubMed

J Virol. 1997 Aug;71(8):6083-93 PubMed

Nature. 1979 Jan 4;277(5691):66-8 PubMed

Arch Virol. 1986;89(1-4):69-80 PubMed

J Immunol. 1996 Oct 15;157(8):3542-9 PubMed

J Virol. 2003 Sep;77(17):9463-73 PubMed

Microbes Infect. 2003 Jun;5(7):571-8 PubMed

Acta Virol. 1986 Sep;30(5):402-10 PubMed

J Virol. 1985 Mar;53(3):944-8 PubMed

J Exp Med. 2000 May 1;191(9):1459-66 PubMed

J Interferon Cytokine Res. 1998 Mar;18(3):159-65 PubMed

Jpn J Ophthalmol. 2002 Jul-Aug;46(4):370-76 PubMed

J Exp Med. 2000 May 1;191(9):1455-8 PubMed

J Virol. 1985 Dec;56(3):930-7 PubMed

J Gen Virol. 1998 Mar;79 ( Pt 3):561-4 PubMed

J Virol. 1990 Jan;64(1):431-6 PubMed

Vaccine. 1988 Jun;6(3):223-8 PubMed

Clin Diagn Lab Immunol. 2004 May;11(3):437-45 PubMed

Vaccine. 1991 Mar;9(3):147-53 PubMed

Clin Infect Dis. 2005 May 1;40(9):1271-81 PubMed

J Gen Virol. 1994 Jun;75 ( Pt 6):1211-22 PubMed

J Interferon Res. 1983;3(4):461-3 PubMed

J Clin Microbiol. 1990 Jan;28(1):11-5 PubMed

Arch Virol. 1989;108(1-2):19-31 PubMed

Infect Immun. 1981 Oct;34(1):192-9 PubMed

J Virol. 2000 Apr;74(8):3909-17 PubMed

J Gen Virol. 2000 Jan;81(Pt 1):1-19 PubMed

Infect Immun. 1983 Aug;41(2):556-62 PubMed

Virus Genes. 2002 Oct;25(2):179-88 PubMed

Acta Virol. 1980 May;24(3):183-93 PubMed

Intervirology. 2003;46(1):25-34 PubMed

Am J Pathol. 2003 Dec;163(6):2179-84 PubMed

Nature. 1995 Jun 1;375(6530):411-5 PubMed

Cell Immunol. 1980 Sep 15;55(1):191-200 PubMed

J Virol. 1992 Jan;66(1):341-8 PubMed

Vaccine. 1991 Oct;9(10):728-34 PubMed

Antiviral Res. 1988 Nov;10(1-3):83-8 PubMed

Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines